K. Shen

Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.

V. Fonseca, H. Foyt, R. Whitcomb, 2000, Diabetes care.

Efficacy and Safety of Degarelix in Taiwanese Patients with Prostate Cancer Requiring Androgen Deprivation Therapy: An Open-label, Multicenter Phase III Study

Chao-yuan Huang, Hsi-Chin Wu, T. Wu, 2016 .

Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial

Xuefei Wang, Yihong Sun, Tianshu Liu, 2022, BMC Medicine.

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

K. Tao, Jun Zhang, Jian Li, 2022, The oncologist.

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.

Y. Wang, A. Schneeweiss, Ming Yan, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.